Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program.
Weiss J, Gibbons K, Ehyaee V, Perez-Silos V, Zevallos A, Maienschein-Cline M, Brister E, Sverdlov M, Shah E, Balakrishna J, Symes E, Frederiksen JK, Gann PH, Post R, Lopez-Hisijos N, Reneau J, Venkataraman G, Bailey N, Brown NA, Xu ML, Wilcox RA, Inamdar K, Murga-Zamalloa C. Weiss J, et al. Among authors: gann ph. Am J Pathol. 2024 Jan;194(1):165-178. doi: 10.1016/j.ajpath.2023.10.008. Epub 2023 Nov 3. Am J Pathol. 2024. PMID: 37923249
The basis and design for time-restricted eating compared with daily calorie restriction for weight loss and colorectal cancer risk reduction trial (TRE-CRC trial).
Gabel K, Fitzgibbon ML, Yazici C, Gann P, Sverdlov M, Guzman G, Chen Z, McLeod A, Hamm A, Varady KA, Tussing-Humphreys L. Gabel K, et al. Obesity (Silver Spring). 2022 Dec;30(12):2376-2385. doi: 10.1002/oby.23579. Epub 2022 Nov 1. Obesity (Silver Spring). 2022. PMID: 36319597 Free PMC article. Clinical Trial.
Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression.
Gamage HEV, Shahoei SH, Albright ST, Wang Y, Smith AJ, Farmer R, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Gupta AD, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER. Gamage HEV, et al. Among authors: gann ph. bioRxiv [Preprint]. 2023 Aug 14:2023.08.14.553229. doi: 10.1101/2023.08.14.553229. bioRxiv. 2023. PMID: 37645737 Free PMC article. Preprint.
NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors.
Vidana Gamage HE, Shahoei SH, Wang Y, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Das Gupta A, Bendre SV, Nguyen T, Tiwari S, Tjoanda E, Krawczynska N, He S, Albright ST, Farmer R, Smith AJ, Fink EC, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Hergenrother PJ, Apetoh L, Nelson ER. Vidana Gamage HE, et al. Among authors: gann ph. Cancer Lett. 2024 Aug 10;597:217042. doi: 10.1016/j.canlet.2024.217042. Epub 2024 Jun 20. Cancer Lett. 2024. PMID: 38908543 Free article.
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells.
Vidana Gamage HE, Albright ST, Smith AJ, Farmer R, Shahoei SH, Wang Y, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Das Gupta A, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER. Vidana Gamage HE, et al. Among authors: gann ph. Cancer Lett. 2024 Aug 10;597:217086. doi: 10.1016/j.canlet.2024.217086. Epub 2024 Jun 27. Cancer Lett. 2024. PMID: 38944231 Free article.
Prostate-derived circulating microRNAs add prognostic value to prostate cancer risk calculators.
Zenner ML, Kirkpatrick B, Leonardo TR, Schlicht MJ, Saldana AC, Loitz C, Valyi-Nagy K, Maienschein-Cline M, Gann PH, Abern M, Nonn L. Zenner ML, et al. Among authors: gann ph. bioRxiv [Preprint]. 2023 Jun 6:2023.05.10.540236. doi: 10.1101/2023.05.10.540236. bioRxiv. 2023. Update in: J Extracell Biol. 2023 Nov;2(11):e122. doi: 10.1002/jex2.122 PMID: 37214878 Free PMC article. Updated. Preprint.
Learning to predict prostate cancer recurrence from tissue images.
Farrokh M, Kumar N, Gann PH, Greiner R. Farrokh M, et al. Among authors: gann ph. J Pathol Inform. 2023 Nov 4;15:100344. doi: 10.1016/j.jpi.2023.100344. eCollection 2024 Dec. J Pathol Inform. 2023. PMID: 39712978 Free PMC article.
Biparametric Quantitative MRI for Prostate Cancer Detection.
Uyanik M, Vigneswaran HT, Hale GR, Gann P, Magin R, Abern MR. Uyanik M, et al. Top Magn Reson Imaging. 2023 Dec 1;32(6):66-72. doi: 10.1097/RMR.0000000000000308. Epub 2023 Nov 15. Top Magn Reson Imaging. 2023. PMID: 38051029 Free PMC article.
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
Carbunaru S, Sun Z, McCall C, Ofori B, Marshall N, Wang H, Abern M, Liu L, Hollowell CMP, Sharifi R, Vidal P, Kajdacsy-Balla A, Sekosan M, Ferrer K, Wu S, Gallegos M, Gann PH, Moreira D, Sharp LK, Ferrans CE, Murphy AB. Carbunaru S, et al. Among authors: gann ph. Cancer Med. 2023 Oct;12(19):19690-19700. doi: 10.1002/cam4.6615. Epub 2023 Oct 3. Cancer Med. 2023. PMID: 37787097 Free PMC article. Clinical Trial.
137 results